Latest papers

Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.

Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.

Inhibitor of κB Kinase Beta Regulates Gastric Carcinogenesis via Interleukin-1α Expression

Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding.

Regulation of NF-kappaB responses by epigenetic suppression of IkappaBalpha expression in HCT116 intestinal epithelial cells.

Prolonged physical training decreases mRNA levels of glucocorticoid receptor and inflammatory genes.

Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.

Population robustness arising from cellular heterogeneity.

Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.

S-Adenosyl-L-methionine ameliorates TNFalpha-induced insulin resistance in 3T3-L1 adipocytes.

Selection of reference genes for quantitative real-time reverse transcription-polymerase chain reaction in concanavalin A-induced hepatitis model

Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome.

Anti-inflammatory effect of a selective IκB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke

Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB.

Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways.

Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity.

Vinpocetine as a potent antiinflammatory agent.

Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism.

Inhibiting NF-κB activation by small molecules as a therapeutic strategy

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.